Braidwell’s Bruker BRKR Stock Holding History

Braidwell’s Portfolio BRKR Stock Details BRKR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-353,200	Closed	-$20.7M	–	67
2024 Q4	$20.7M	Buy	+353,200	New	+$20.9M	0.61%	49

Other funds holding BRKR

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PCA

Pallas Capital Advisors Braintree, Massachusetts $3.25B AUM 40.07% 1-Year Est. Return

LCOV

London Company of Virginia Richmond, Virginia $17.5B AUM 29.92% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Braidwell's BRKR Position: Q1 2025 in Review

Braidwell sold out of Bruker (BRKR) in Q1 2025, closing a stake of 353,200 shares — an estimated $20.7M sold.

Braidwell first reported a position in BRKR in Q4 2024 and held it in 1 quarter. The position peaked at $20.7M in Q4 2024. 399 funds tracked by Wall St. Rank hold BRKR as of Q1 2025.

Braidwell reported no remaining Bruker position as of Q1 2025 after selling out during the quarter.
Braidwell sold 353,200 Bruker shares in Q1 2025, an estimated $20.7M.
Braidwell first reported a position in Bruker in Q4 2024 and held it in 1 quarter.
Braidwell's Bruker position peaked at $20.7M in Q4 2024.
399 funds tracked by Wall St. Rank held Bruker as of Q1 2025.

Based on Braidwell's 13F filing for Q1 2025, filed 15 May 2025.